Christof Sohn

Biochemistry, Genetics and Molecular Biology · Life Sciences

64h-index19.3kcitations638works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(113), HER2/EGFR in Cancer Research(60), Cancer Cells and Metastasis(55), Breast Lesions and Carcinomas(53), BRCA gene mutations in cancer(50)

Publications612 total

Supplementary Table 4 from Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
2023Open Access
Supplementary Figure 1 from Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
2023Open Access
Supplementary Figure 3 from Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
2023Open Access
Data from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
2023Open Access
Supplementary Figure 1 from Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
2023Open Access
Supplementary Table 1 from Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
2023Open Access
Data from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
2023Open Access
Supplementary Table 2 from Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
2023Open Access
Supplementary Figure 3 from Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
2023Open Access
Supplementary Table 2 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
2023Open Access
Supplementary Table 1 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
2023Open Access
Supplementary Figure Legend from Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
2023Open Access
Supplementary Table Legend from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
2023Open Access
Supplementary Figure 2 from Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
2023Open Access
Supplementary Table 1 from Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
2023Open Access
Supplementary Table 2 from Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
2023Open Access
Supplementary Table 5 from Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
2023Open Access
Data from Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
2023Open Access
Supplementary Table 1 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
2023Open Access
Supplementary Table 3 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
2023Open Access
page 1 of 31Next →

Frequent Co-authors

Andreas Schneeweiß(29), Barbara Burwinkel(22), Frederik Marmé(15), Marjanka K. Schmidt(14), Stig E. Bojesen(14), Børge G. Nordestgaard(14), Annegien Broeks(14), Jenny Chang‐Claude(12), Heli Nevanlinna(12), Carl Blomqvist(12), Henrik Flyger(12), Thilo Dörk(12), Sarah Schott(12), Isabel dos‐Santos‐Silva(11), Kristiina Aittomäki(11), John L. Hopper(11), Melissa C. Southey(11), Diether Lambrechts(11), Peter A. Fasching(11), Arif B. Ekici(11)